Private Insurers Pay 241 Percent of What Medicare Would Pay
Prices paid to hospitals for privately insured patients in 2017 averaged 241 percent of what Medicare would have paid.
Prices paid to hospitals for privately insured patients in 2017 averaged 241 percent of what Medicare would have paid.
A study presented at the Academy of Managed Care Pharmacy Managed Care and Specialty Pharmacy 2019 Annual Meeting showed that an oral oncology split-fill program implemented by AllianceRx Walgreens Prime resulted in improved adherence and reduced pharmacy costs and medication waste.
Changes in access to care from 2010 to 2016 were evaluated.
Patients with cancer may face differences in outcome depending on risk adjustment based on Medicare administrative data.
Soaring costs for cancer drugs are detrimental to patient care in the United States, say a group of oncologists.
Patient demographics and cancer type are major contributing factors for the variation in rates of insurance coverage.
Exact Sciences Corp., maker of Cologuard, announced that several insurers are now covering the non-invasive colon cancer at-home test.
Uninsured patients may be charged anywhere from two to 43 times what private insurance plans or Medicare pay for chemotherapy medications.
We polled 349 oncology professionals to see how The Affordable Care Act has impacted them and their practice. See how your colleagues responded.
Representatives from ASCO held a Congressional briefing to detail their new report’s findings.